Children with psychosomatic disorders
Conditions
Interventions
1. Electromagnetic informed consent/assent will be obtained for children aged 11-18 years who visit the principal or submitting institution for pediatric psychosomatic disorders (truancy, orthostatic
s management number when entered into the tablet will be managed in a corresponding table to protect personal information. Subjects will install the cognitive-behavioral therapy application "
Mugimaru 2"
on their own smartphones using QR codes, and will implement the loaded program over a period of 2 to 4 weeks. The evaluation items (QTA30, PHQ-9A) included in the application will be administered i
on their own smartphones using a QR code. The program will be implemented over a period of 2 to 4 weeks. 3. The assessment items (QTA30, PHQ-9A) included
Sponsors
Fukuoka University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet the following conditions who visited the medical institution of the principal investigator and sub-researcher. Pediatric psychosomatic diseases (truancy, orthostatic dysregulation, eating disorder, sleep disorder, etc.) Allergic diseases (food allergy, bronchial asthma, etc). Endocrine disorders (short stature, obesity, etc.) Target group II: Students attending model junior high and high schools in Fukuoka City. Target age: 13-18 years old (junior high school and high school students)
Exclusion criteria
Exclusion criteria: At the time of entry and at the time of checkpoint, the subjects checked more than half of the time in two weeks or almost every day in question item 9 of PHQ-9A of the depression screening scale, "How often have you felt like dying in the past two weeks? Subjects who checked more than half of the questions in the past two weeks and almost every day at the checkpoint. Those who cannot answer the questionnaire. Those who do not own a smart phon
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of differences in the improvement of health scales between the application and non-application groups immediately after, 3 months after, and 6 months after the application. | — |
Countries
Japan
Contacts
Public ContactShinichiro Nagamitsu
Fukuoka University Department of Pediatrics
Outcome results
None listed